Related Experiment Video
Updated: Jul 30, 2025

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
Natriuretic peptides as predictors for atrial fibrillation recurrence after catheter ablation: A meta-analysis
Yujing Yuan1, Boyuan Nie2, Binbin Gao1
1Department of Cardiology, Shanxi Cardiovascular Hospital, Taiyuan, Shanxi, People's Republic of China.
Insights
Higher baseline natriuretic peptide levels, including atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), predict atrial fibrillation (AF) recurrence after catheter ablation (CA). These findings highlight natriuretic peptides as potential biomarkers for AF management post-CA.
Area of Science:
- Cardiology
- Biomarkers
- Electrophysiology
Background:
- Catheter ablation (CA) is a primary treatment for atrial fibrillation (AF), but recurrence remains a significant clinical challenge.
- Identifying predictors of AF recurrence post-CA is crucial for optimizing patient outcomes and treatment strategies.
Approach:
- A comprehensive meta-analysis was conducted, systematically searching major scientific databases (PubMed, EMBASE, Web of Science, Wiley-Cochrane Library) up to May 2022.
- Sixty-one studies were included, analyzing baseline natriuretic peptide levels in relation to AF recurrence after CA using overall and subgroup effect analyses.
Key Points:
- Elevated baseline levels of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), N-terminal pro-BNP, and midregional N-terminal pro-ANP were significantly associated with increased AF recurrence.
- Specific standardized mean differences (SMDs) and 95% confidence intervals (CIs) were reported for each peptide, indicating the strength of association.
Conclusions:
- Increased baseline natriuretic peptide concentrations are linked to a higher risk of AF recurrence following catheter ablation.
- Further research is warranted to fully elucidate the predictive utility of these natriuretic peptides in AF patients undergoing CA.
Background:
Catheter ablation (CA) has become the first-line treatment strategy for atrial fibrillation (AF) but remains with a substantial recurrence rate. The aim of this meta-analysis was to determine the association between baseline natriuretic peptide levels and AF recurrence after CA.
Methods:
We systematically searched PubMed, EMBASE, Web of Science, and Wiley-Cochrane Library for relevant studies published up until May 2022. Overall effect analysis and subgroup analysis were performed with Review Manager software.
Results:
Finally, 61 studies that met the inclusion criteria were included in our meta-analysis. Compared with the nonrecurrence group, the recurrence group had increased baseline level of atrial natriuretic peptide (ANP) (standardized mean difference [SMD] = 0.39, 95% confidence interval [CI]: 0.21-0.56), brain natriuretic peptide (BNP) (SMD = 0.51, 95% CI: 0.31-0.71), N-terminal pro-BNP (SMD = 0.71, 95% CI: 0.49-0.92), and midregional N-terminal pro-ANP (SMD = 0.91, 95% CI: 0.27-1.56).
Conclusions:
Increased baseline natriuretic peptide levels, including ANP, BNP, N-terminal pro-BNP, and midregional N-terminal pro-ANP, are associated with a higher risk of AF recurrence after CA. Nonetheless, further studies are needed to elucidate the predictive value of baseline natriuretic peptides in AF patients undergoing CA.
More Related Videos
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
06:48Three-Dimensional Echocardiographic Method for the Visualization and Assessment of Specific Parameters of the Pulmonary Veins
Published on: October 28, 2020
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure II: Pathophysiology
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Heart Failure Drugs: Diuretics
Cardiac Catheterization IV: Nursing Management